Stockreport

Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures

ABIOMED, Inc.  (ABMD) 
Last abiomed, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.abiomed.com/investor-relations
PDF DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announ [Read more]